PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 46 filers reported holding PASSAGE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,648,629 | -29.8% | 2,497,922 | 0.0% | 2.12% | +5.0% |
Q2 2023 | $2,348,047 | -2.1% | 2,497,922 | 0.0% | 2.02% | +1.8% |
Q1 2023 | $2,398,005 | -30.4% | 2,497,922 | 0.0% | 1.98% | -20.6% |
Q4 2022 | $3,447,132 | +10.4% | 2,497,922 | 0.0% | 2.50% | +34.8% |
Q3 2022 | $3,122,000 | -47.0% | 2,497,922 | 0.0% | 1.85% | -51.5% |
Q2 2022 | $5,895,000 | -23.9% | 2,497,922 | 0.0% | 3.82% | +0.1% |
Q1 2022 | $7,744,000 | -51.2% | 2,497,922 | 0.0% | 3.82% | -33.6% |
Q4 2021 | $15,862,000 | -36.2% | 2,497,922 | 0.0% | 5.75% | -19.9% |
Q3 2021 | $24,879,000 | +1591.3% | 2,497,922 | 0.0% | 7.18% | +1798.4% |
Q2 2021 | $1,471,000 | -96.6% | 2,497,922 | 0.0% | 0.38% | -96.3% |
Q1 2021 | $43,664,000 | -31.6% | 2,497,922 | 0.0% | 10.16% | -31.1% |
Q4 2020 | $63,872,000 | +95.0% | 2,497,922 | 0.0% | 14.76% | +11.8% |
Q3 2020 | $32,748,000 | -52.0% | 2,497,922 | 0.0% | 13.20% | -32.6% |
Q2 2020 | $68,268,000 | +73.5% | 2,497,922 | 0.0% | 19.59% | +66.4% |
Q1 2020 | $39,342,000 | – | 2,497,922 | – | 11.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
Annandale Capital, LLC | 54,338 | $51 | 0.02% |